Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hecker

Showing results (271-280 of 379) with videos related to

Pageof 38
Sort By:
International Journal of Medical Microbiology : IJMM|January 25, 2014
The phosphoproteome and its physiological dynamics in Staphylococcus aureusKatrin Bäsell, Andreas Otto, Sabryna Junker, et al.
Journal of Neuroinflammation|June 26, 2012
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevanceAlexander Hundeshagen, Michael Hecker, Brigitte Katrin Paap, et al.
The Journal of Biological Chemistry|February 21, 2004
Structure-function analysis of PrsA reveals roles for the parvulin-like and flanking N- and C-terminal domains in protein folding and secretion in Bacillus subtilisMarika Vitikainen, Ilkka Lappalainen, Raili Seppala, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2011
Global analysis of the Staphylococcus aureus response to mupirocinSwantje Reiss, Jan Pané-Farré, Stephan Fuchs, et al.
Pharmaceutics|March 26, 2022
Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without PolypharmacyPaula Bachmann, Niklas Frahm, Jane Louisa Debus, et al.
Neurology and Therapy|July 3, 2026
Polypharmacy, Potential Drug-Drug Interactions and Medication Non-Adherence in Patients with Multiple Sclerosis: A Longitudinal StudyAvinash M Suntah, Michael Hecker, Bassel Barhoum, et al.
Therapeutic Advances in Drug Safety|April 3, 2023
Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancyMarie-Celine Haker, Niklas Frahm, Michael Hecker, et al.
Molecular & Cellular Proteomics : MCP|May 5, 2012
Life and death of proteins: a case study of glucose-starved Staphylococcus aureusStephan Michalik, Jörg Bernhardt, Andreas Otto, et al.
Journal of Clinical Medicine|April 26, 2025
Trauma Burden Affected People with Multiple Sclerosis During SARS-CoV-2 PandemicFelicita Heidler, Michael Hecker, Niklas Frahm, et al.
Microbial Cell Factories|April 9, 2008
Towards the development of Bacillus subtilis as a cell factory for membrane proteins and protein complexesJessica C Zweers, Imrich Barák, Dörte Becher, et al.
Pageof 38

Showing results (271-280 of 379) with videos related to

Sort By:
Pageof 38
International Journal of Medical Microbiology : IJMM|January 25, 2014
The phosphoproteome and its physiological dynamics in Staphylococcus aureusKatrin Bäsell, Andreas Otto, Sabryna Junker, et al.
Journal of Neuroinflammation|June 26, 2012
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevanceAlexander Hundeshagen, Michael Hecker, Brigitte Katrin Paap, et al.
The Journal of Biological Chemistry|February 21, 2004
Structure-function analysis of PrsA reveals roles for the parvulin-like and flanking N- and C-terminal domains in protein folding and secretion in Bacillus subtilisMarika Vitikainen, Ilkka Lappalainen, Raili Seppala, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2011
Global analysis of the Staphylococcus aureus response to mupirocinSwantje Reiss, Jan Pané-Farré, Stephan Fuchs, et al.
Pharmaceutics|March 26, 2022
Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without PolypharmacyPaula Bachmann, Niklas Frahm, Jane Louisa Debus, et al.
Neurology and Therapy|July 3, 2026
Polypharmacy, Potential Drug-Drug Interactions and Medication Non-Adherence in Patients with Multiple Sclerosis: A Longitudinal StudyAvinash M Suntah, Michael Hecker, Bassel Barhoum, et al.
Therapeutic Advances in Drug Safety|April 3, 2023
Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancyMarie-Celine Haker, Niklas Frahm, Michael Hecker, et al.
Molecular & Cellular Proteomics : MCP|May 5, 2012
Life and death of proteins: a case study of glucose-starved Staphylococcus aureusStephan Michalik, Jörg Bernhardt, Andreas Otto, et al.
Journal of Clinical Medicine|April 26, 2025
Trauma Burden Affected People with Multiple Sclerosis During SARS-CoV-2 PandemicFelicita Heidler, Michael Hecker, Niklas Frahm, et al.
Microbial Cell Factories|April 9, 2008
Towards the development of Bacillus subtilis as a cell factory for membrane proteins and protein complexesJessica C Zweers, Imrich Barák, Dörte Becher, et al.
Pageof 38